Interim report Q1 2022
Scandion Oncology’s Executive Management will host a webcast and conference call at 10:00 CET
Loading view.
Økonomisk Ugebrev Life science investor konference
Copenhagen , DenmarkMeet Scandion Oncology at Økonomisk Ugebrev Life Science Investor Konference
Redeye Growth Day 2022
Stockholm , SwedenMeet Scandion Oncology at Redeye Growth Day 2022
Scandion Oncology webcast and conference call
Scandion Oncology’s Executive Management will host a webcast and conference call presenting the upcoming Rights Issue.
BIO International Convention 2022
San Diego CA, United StatesMeet Scandion Oncology at BIO International Convention 2022
Aktiespararna Småbolagsdagarna 2022
Stockholm , SwedenMeet Scandion Oncology at Aktiespararna Småbolagsdagarna 2022
Redeye Transactions
Meet Scandion Oncology at Redeye Transactions
EACR 2022
Sevilla , SpainMeet Scandion Oncology at the EACR 2022 Congress
BACR
Nottingham , United KingdomMeet Scandion Oncology at the BACR 60th Anniversary Meeting
Interim report Q2 2022
Scandion Oncology (Scandion) will publish its Q2 2022 interim report on Thursday, August 25, 2022 before 09:00 CET. Scandion’s Executive Management will host a webcast and conference call the same day at 10:00 CET presenting the results and a company update. At the end of the presentation there will be a Q&A session. Access to the event can be obtained as follows: LIVE access on Thursday August 25, 2022 at 10:00 CET https://financialhearings.com/event/43548
LSX Nordic Congress
Copenhagen , DenmarkMeet Scandion Oncology at LSX Nordic 2022
Conference call on CORIST
Our Executive Management will host a webcast and conference call.